One third of Brits stockpile drugs
June 24, 2019Sales and Marketing UK, medicine, pharma, pharmaceuticals, stockpiling
A third (33%) of brits stockpile medicines, according to new research from Co-op Health. One in three British people never …
Top Ten most popular articles on Pharmafile.com this week
June 21, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, MSD, Parkinson's, blockchain, brexit, top ten
It’s Friday, and time for another run-down of the week’s most popular articles.
European approval for Novo’s Esperoct in haemophilia A
June 21, 2019Medical Communications, Sales and Marketing Esperoct, Novo Nordisk, haemophilia, pharma
The European Commission has awarded approval to Novo Nordisk’s extended half-life factor VIII therapy Esperoct (turoctocog alfa pegol, N8-GP) for …
Sanofi to axe 466 R&D positions in Germany and France
June 21, 2019Medical Communications, Research and Development, Sales and Marketing Sanofi, pharma
Sanofi has announced that plans to reorganise its research and development operations will result in the losses of 466 jobs …
GSK offers concessions ahead of planned venture with Pfizer
June 21, 2019Medical Communications, Sales and Marketing GSK, Pfizer, pharma
The European Commission has said that GlaxoSmithKline has offered concessions to address concerns relating to the British multinational’s planned joint …
Alimera Sciences secures NICE recommendation for uveitis eye implant
June 21, 2019Medical Communications, Sales and Marketing Alimera Sciences, NICE, UK, pharma, uveitis
Britain’s cost effectiveness body NICE has recommended the use of the fluocinolone acetonide implant, a new treatment option for patients …
Catalent to purchase Italy manufacturing facility from BMS
June 20, 2019Manufacturing and Production, Sales and Marketing BMS, Bristol-Myers Squibb, Cataletnt, pharma
Bristol-Myers Squibb has reached an agreement with Catalent for the latter to acquire its Anagni, Italy-based facility which specialises in …
Scientists at King’s College London identify early signs of Parkinson’s disease
June 20, 2019Research and Development King's College London, Kings College London, Parkinson's disease, pharma, serotonin
Scientists at King’s College London say they have identified the earliest signs of Parkinson’s disease in the brain – 15 …
Gilead signs deal with Nurix Therapeutics worth more than $2.3 billion
June 20, 2019Business Services, Research and Development Gilead, Nurix Therapeutics, pharma, protiens
Gilead has signed a deal with San Francisco biotech Nurix Therapeutics – a company focused on developing drugs that control …
GSK launch sale of consumer healthcare brands
June 20, 2019Business Services GSK, Pfizer, consumer health, pharma, portfolio
British multinational GlaxoSmithKline (GSK) has launched a sale of some of its consumer healthcare brands. The sale comes as GSK …
No-deal Brexit could cause shortages and higher prices, healthcare distributors warn
June 19, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, brexit, distribution, pharma, supply chain
The Healthcare Distribution Association (HDA) has warned MPs that Britain could face shortages of medicines if it were to leave …
NICE recommends Amgen’s Blincyto in rare acute lymphoblastic leukaemia sub-population
June 19, 2019Research and Development, Sales and Marketing Amgen, Cancer, NICE, acute lymphoblastic leukaemia, blincyto, pharma
Patients on the NHS in England and Wales will now be able to access Amgen’s Blincyto (blinatumomab) after NICE reveals …
Contract manufacturing services industry set to grow at CAGR of 10.6% between 2017-2027
June 19, 2019Research and Development EU, Europe, biopharma, contract manufacturing services, manufacturing, pharma
The biopharmaceutical contract manufacturing market is expected to grow at a compound annual growth rate (CAGR) of 10.6% between 2017 …
MSD’s Keytruda snatches up first approval in small cell lung cancer
June 19, 2019Research and Development, Sales and Marketing Cancer, FDA, MSD, US, keytruda, lung cancer, pharma
MSD has revealed that its anti-PD-1 immunotherapy Keytruda (pembrolizumab) has been awarded marketing authorisation from the FDA as a monotherapy …
EU pharmaceutical industry lost €16.5 billion in sales as staff shift to patent infringing firms
June 19, 2019Research and Development EU, counterfeit, generics, pharma, sales
A report from the European Union Intellectual Property Office (EUIPO) has said ‘counterfeit’ drugs cost the EU pharmaceutical industry €16.5 …
FDA expand Paragraph IV Patent Certifications List for generic drugmakers
June 19, 2019Research and Development FDA, Hatch-Waxman act, generic drugs, generics, pharma
The FDA has said that it is expanding a database used by generic drugmakers to get information on when their …
EU approval for MSD and AZ’s Lynparza in first-line BRCA-mutated advanced ovarian cancer
June 18, 2019Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, MSD, lynparza, ovarian cancer, pharma
AstraZeneca and MSD’s jointly-developed therapy Lynparza (olaparib) has scored its third EU approval, the pair announced, with authorisation for the …
Roche secures world first with Japanese Rozlytrek approval in advanced recurrent solid tumours
June 18, 2019Manufacturing and Production, Sales and Marketing Cancer, Japan, Roche, Rozlytrek, pharma
Roche’s personalised cancer therapy Rozlytrek (entrectinib) has seen its first approval: the drug has been approved in Japan for the …
MHRA recall M&A Pharmachem’s paracetamol due to fungal contamination
June 18, 2019Manufacturing and Production Contamination, MHRA, fungal, paracetamol, pharma
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a recall of M&A Pharmachem’s 500mg paracetamol tablets. The …
FDA approves Novo Nordisk’s Victoza for children with type 2 diabetes
June 18, 2019Manufacturing and Production GLP-1, Novo Nordisk, Victoza, diabetes, liraglutide
The FDA has approved Novo Nordisk’s Victoza (liraglutide) for paediatric patients aged 10 years and older with type 2 diabetes. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
